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1991-7902/Copyrightª 2015, AssociatioAbstract Background/purpose: Cigarette smoking is an important risk factor in the patho-
genesis of periodontal disease. Little is known about the effects of nicotine, the major compo-
nent of cigarette smoke, on cementoblasts. The aim of this study was to investigate the
cytopathologic effects of nicotine on murine immortalized cementoblast cell line (OCCM.30).
Materials and methods: Cell viability was judged by using the tetrazolium bromide reduction
assay. Cell differentiation was examined by alkaline phosphatase assay. The production of
prostaglandin E2 (PGE2) and nitric oxide (NO) were evaluated using an enzyme-linked immuno-
sorbent assay and Griess reaction, respectively. Inducible nitric oxide synthase (iNOS) was
evaluated by western blot.
Results: Nicotine demonstrated cytotoxicity to cementoblasts in a dose-dependent manner
(P < 0.05). Nicotine was found to inhibit alkaline phosphatase activity in a time-dependent
manner (P < 0.05). In addition, nicotine increased the secretion of PGE2 in a dose-
dependent manner (P < 0.05). Nicotine was found to induce NO generation and iNOS expres-
sion in a dose-dependent manner (P < 0.05).
Conclusion: Our results suggest that nicotine could inhibit cementoblast growth and differen-
tiation. In addition, nicotine could also induce the inflammatory effects by the augmentation
of PGE2 secretion and iNOS/NO expression.
Copyright ª 2015, Association for Dental Sciences of the Republic of China. Published by Else-
vier Taiwan LLC. All rights reserved.ntistry, Chung Shan Medical University, 110, Section 1, Chien-Kuo N. Road, Taichung, Taiwan.
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Studies have been reported that the role of cigarette
smoking is a major modifiable environmental risk factor for
periodontal disease.1,2 In addition, cigarette smokers are
found to increase three to six times more likely to have
periodontitis than nonsmokers.3,4 Xenobiotics derived from
cigarette smoking are the important negative effect on the
response to periodontaltherapy.5
Tobacco smoke contains more than 4000 different
chemical compounds, the most studied of which is nicotine.
Nicotine, a major component of cigarette smoke/cigarette
smoke extract, has been detected on the root surface of
periodontally involved teeth6 and may alter some cellular
functions (e.g., inhibiting cell viability and attachment).7,8
Periodontitis is a chronic inflammatory disease. Previous
studies have reported that nicotine could induce inflam-
matory mediators, such as cyclooxygenase-2,9,10 inter-
leukin (IL)-1, IL-6, IL-8, and tumor necrosis factor-alpha
(TNF-a).11,12 In addition, reactive oxygen species levels are
related to bony destruction in periodontitis.13 Recently, we
found that nicotine can upregulate the generation of
reactive oxygen species in cementoblasts.12 Despite the
lines of evidence cited above, the cytopathologic effects of
nicotine remain to be elucidated.
Cementum is a mineralized tissue lining the surface of
tooth root, and shares numerous similarities with bone in
terms of composition, mechanical properties, and disease
responsiveness.14 Cementoblasts are highly differentiated
with a capacity to form reparative cementum. The stimu-
lation of cementoblast proliferation and differentiation is
important to regenerate damaged periodontal tissues.
However, little is known about the cytopathologic effects
of nicotine on cementoblasts. In the present study, the
effects of nicotine on murine immortalized cementoblast
cell line (OCCM.30) were determined by measuring cyto-
toxicity, alkaline phosphatase (ALP) assay, prostaglandin E2
(PGE2) production, nitric oxide (NO) generation, and
inducible nitric oxide synthase (iNOS) expression.Materials and methods
Cell culture
Immortalized murine cementoblasts (OCCM.30) were a
generous gift from Dr Somerman’s laboratory (University of
Washington, Seattle, WA, USA).15 Cells were grown in Dul-
becco’s modified Eagle’s medium (Gibco BRL, Gaithersburg,
MD, USA), supplemented with 10% fetal calf serum and
antibiotics (Gibco BRL). Cultures were maintained at 37C
in a humidified atmosphere of 5% CO2 and 95% air. Confluent
cell layers were treated with 0.25% trypsin and 0.05% EDTA
for 5 minutes.
Cytotoxicity assay
The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium
bromide (MTT; Sigma Chemical Co., St. Louis, MO, USA)
solution was prepared in 5 mg/mL phosphate-buffered sa-
line (PBS) prior to use and filtered through a 0.22-mmfilter.16,17 Nicotine in medium was prepared from a 1 mg/
mL stock solution of pure nicotine (Sigma Chemical Co.) in
distilled water, which was prepared fresh prior to each
experiment. The cells were incubated with or without
different concentrations of nicotine for 24 hours. Briefly,
2  104 cells were seeded to a 96-well plate in 100 mL
medium and left overnight to attach. Serial dilutions of
nicotine in 100-mL volumes were added, and cells were
treated for 20 hours. After treatment, 50 ml of the MTT
solution (2 mg/mL in PBS) was added to each well and
incubated for another 4 hours at 37C. To each well, 50 mL
of dimethyl sulfoxide was added. Plates were then shaken
until the crystals were dissolved. Reduced MTT was then
measured spectrophotometrically in a dual beam microtiter
plate reader at 570 nm with a 650-nm reference.
Measurement of ALP activity
ALP activity was evaluated using a substrate assay as
described previously.18 The cells were also incubated with
or without 0.5mM nicotine for a 3-day culture period.
Briefly, cell lysates were sonicated on ice bath; this was
followed by centrifugation at 1500 g for 5 minutes, and the
ALP activity in supernatant was measured using ALP assay
mixtures containing 0.1M 2-amino-2-methyl-1-propanol,
1mM MgCl2, and 8mM p-nitrophenyl phosphate disodium.
After incubation at 37C for 30 minutes, the reaction was
stopped with 0.1 N NaOH, and the absorbance was read at
405 nm. The OD of control cells was considered to be 100%.
The relative ALP activity was calculated using the following
formula: [optical density (OD) of experimental sample/OD
of control cells]  100%. Each value was expressed as the
mean  standard deviation.
Measurement of PGE2
The protein concentrations of PGE2 were measured with
enzyme-linked immunosorbent assay (ELISA).19 Briefly,
5  104 cells were incubated with or without nicotine for
the indicated periods. The cells were also incubated with or
without different concentrations of nicotine for 24 hours.
The cytokine levels in culture medium were measured using
the ELISA kit (eBiosciences, San Diego, CA, USA) according
to the manufacturer’s instructions.
Nitrite assay
The nitrite concentration in the supernatant was measured
as an indicator of NO production detected by the Griess
reaction.20 The cells were incubated with or without
different concentrations of nicotine for 8 hours. Briefly,
5  104 cells were seeded in 24-well plates for 24 hours,
treated with different concentrations of nicotine. Fifty
microliters of the culture medium was mixed with an equal
volume of Griess reagent (1% sulfanilamide in 5% phosphoric
acid and 0.1% naphthyl-ethylenediamine dihydrochloride in
distilled water) and then shaken for 10 minutes at room
temperature. The absorbance at 540 nm was determined
with a microplate reader. The nitrite concentration was
compared with a standard curve generated with known
concentrations of sodium nitrite.
Figure 1 Cytotoxicity of various concentrations of nicotine
on cementoblasts as measured by MTT assay. Each point and
bar represent a mean  SD. MTT Z 3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyl tetrazolium bromide; SD Z standard devia-
tion. *Significant differences from control values with
P < 0.05.
Figure 2 Effects of nicotine on the alkaline phosphatase
(ALP) activity in cementoblasts. The percentages of ALP ac-
tivity in the presence of 0.5mM nicotine relative to that in the
control are shown during a 3-day culture period. The results
were averaged from three independent experiments. *Signifi-
cant differences from control values with P < 0.05.
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For western blot analysis, cell lysates were collected as
described previously.9 The cells were incubated with or
without different concentrations of nicotine for 8 hours.
Briefly, cells were solubilized with sodium dodecyl sulfate-
solubilization buffer (5mM EDTA, 1mM MgCl2, 50mM
TriseHCl, pH 7.5 and 0.5% Trition X-100, 2mM phenyl-
methysulfonyl fluoride, and 1mM N-ethylmaleimide) for 30
minutes on ice. Then, cell lysates were centrifuged at
12,000 g at 4C, and the protein concentrations were
determined with Bradford reagent using bovine serum al-
bumin as standards. Equivalent amounts of total protein
per sample of cell extracts were run on a 10% sodium
dodecyl sulfate-polyacrylamide gel electrophoresis and
immediately transferred to nitrocellulose membranes. The
membranes were blocked with PBS containing 3% bovine
serum albumin for 2 hours, rinsed, and then incubated with
primary antibodies anti-iNOS (sc-650; Santa Cruz Biotech-
nology, Santa Cruz, CA, USA) (1:1000) in PBS containing
0.05% Tween 20 for 2 hours. After three washes with Tween
20 for 10 minutes, the membranes were incubated for 1
hour with biotinylated secondary antibody diluted 1:1000 in
the same buffer, washed again as described above, and
then treated with 1:1000 streptavidineperoxidase solution
for 30 minutes. After a series of washing steps, protein
expression was detected by chemiluminescence using an
enhanced chemiluminescence detection kit (Amersham
Biosciences UK Limited, Buckinghamshire, UK), and relative
photographic density was quantitated using scanning the
photographic negatives on a gel documentation and anal-
ysis system (AlphaImager 2000’; Alpha Innotech Corp., San
Leandro, CA). Each densitometric value was expressed as
the mean  standard deviation.
Statistical analysis
Three replicates of each concentration were performed in
each test. All assays were repeated three times to ensure
reproducibility. Statistical analysis was carried out with the
Student t test, and a value of P < 0.05 was considered
statistically significant.
Results
Nicotine was cytotoxic to OCCM.30 cells from concentra-
tions higher than 0.5mM over a 24-hour culture period in a
dose-dependent manner (P < 0.05). Fig. 1 shows the per-
centage of cell survival rate compared with controls
following treatment with various concentrations of nico-
tine. The 50% inhibition concentration of nicotine was
about 1mM.
The effects of nicotine on ALP activity were determined
using the substrate assay. As shown in Fig. 2, ALP activity
was found to be significantly decreased after 0.5mM nico-
tine over the 3-day culture period (P < 0.05). The relative
ALP activities were 84%, 68%, 57%, and 38% after 12, 24, 48,
and 72 hours, respectively, as compared with the controls.
The effect of nicotine on the secretion of PGE2 in
OCCM.30 cells by ELISA assay is shown in Fig. 3. The con-
centrations of nicotine higher than 0.5mM weredemonstrated to increase PGE2 secretion in a dose-
dependent manner (P < 0.05). The levels of PGE2 were
1065, 1128, 1272, 1503, 1671, and 1478 pg/mL at the con-
centrations of 0, 0.125, 0.25, 0.5, 1, and 1.5mM nicotine,
respectively.
To evaluate the effects of nicotine on NO production in
OCCM.30 cells, nitrite accumulation was examined using
the Griess assay. As shown in Fig. 4, nicotine was found to
induce nitrite generation in a dose-dependent manner
(P < 0.05). The levels of NO were 2.9-, 3.4-, 4.7-, 6.5-, and
4.9-fold at the concentrations of 0.125, 0.25, 0.5, 1, and
1.5mM nicotine, respectively, as compared with the
controls.
To investigate whether nicotine may induce NO pro-
duction via the induction of the corresponding gene
Figure 3 Effects of nicotine on the expression of PGE2 on
cementoblasts by ELISA. Cells were stimulated with the indi-
cated concentrations of nicotine for 24 hours. Values are
expressed as mean  SD. ELISA Z enzyme-linked immunosor-
bent assay; PGE2 Z prostaglandin E2; SD Z standard devia-
tion. *Significant difference from control values with P < 0.05.
Figure 5 Effects of nicotine on iNOS expression by western
blot. (A) Cells were exposed to various nicotine concentrations
as indicated. b-Actin was performed in order to monitor equal
protein loading. (B) Levels of iNOS protein treatment with
nicotine were measured by a densitometer. The relative level
of iNOS protein expression was normalized against b-actin
signal and the control was set as 1.0. Optical density values
represent the mean  SD. iNOS Z Inducible nitric oxide syn-
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blots (Fig. 5A). Nicotine was found to induce significant
iNOS protein expression in a dose-dependent manner
(P < 0.05). As shown in Fig. 5B, the levels of iNOS was
significantly increased about 2.2-, 2.8-, 3.7-, and 2.5-fold at
the concentrations of 0.125, 0.25, 0.5, and 1mM nicotine as
compared with the controls, respectively.thase; SD Z standard deviation. *Significant difference from
control values with P < 0.05.Discussion
Previous studies have shown that nicotine is a cytotoxic
agent to periodontal ligament fibroblasts,7,8 human gingivalFigure 4 Effects of nicotine on NO generation. OCCM.30 cells
were stimulated with the indicated concentrations of nicotine.
The supernatant was harvested and detected by Griess reac-
tion. Values are expressed as mean  SD (n Z 3). NO Z nitric
acid; SD Z standard deviation. *Significant difference from
control values with P < 0.05.fibroblasts,21 human buccal mucosal fibroblasts,22 osteo-
blasts,23 and cememtoblasts.12 In this study, nicotine
exhibited cytotoxicity to OCCM.30 cells. These have clearly
shown the cytotoxic nature of nicotine. In addition, the
cytotoxicity of nicotine is not cell type-specific.
ALP is a membrane-bound glycoprotein, which is one of
the osteogenic differentiation markers considered to indi-
cate the presence of osteoblast and the formation of new
bone. Cementum is a mineralized tissue, similar in
composition and properties to bone. To the best of our
knowledge, this is the first report that nicotine could inhibit
ALP activity in OCCM.30 cells. This drop in ALP is consistent
with the reports of decreased ALP expression in the human
osteosarcoma cell line Saos-224 and MG63 cells.25 Taken
together, cigarette smoking may impair the mineralization
of collagenous bone matrix by cementoblasts.
PGE2 is one of the proinflammatory mediators has been
implicated as a key mediator in the pathogenesis of peri-
odontal disease.26 Previous studies have shown the upre-
gulation of PGE2 by nicotine on human neutrophils27 and
monocytes.28 Our results also demonstrated that nicotine
could increase PGE2 secretion in OCCM.30 cells. Thus, the
pathogenesis of periodontal diseases may be affected by
alterations in the inflammatory response by cigarette
smoking.
NO is a gaseous, colorless, highly reactive, short-lived
free radical that plays the role of an intracellular
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However, overexpression of NO could result in acute or
chronic inflammatory diseases.29 NO is generated by iNOS
conversion of L-arginine to L-citrulline.30 In addition, iNOS is
involved in the regulation of inflammatory reactions. In the
present study, we first found that nicotine could stimulate
NO generation and iNOS expression in OCCM.30 cells.
Similar results were found that nicotine could induce iNOS
expression and NO production in human gingival fibro-
blasts31 and HPV16-immortalized human periodontal liga-
ment cells.32 Consistently, Wadhwa et al.33 reported that
cigarette smokers with chronic periodontitis exhibited an
increase in serum and saliva NO levels compared with
nonsmokers with chronic periodontitis. Taken together,
nicotine may lead to NO generation and result in inflam-
matory reaction during cigarette smoking.
These results indicate that nicotine is a cytotoxic agent
to cementoblasts by inhibiting cell viability and differenti-
ation. In addition, nicotine could upregulate the secretion
of PGE2 and the generation of NO. However, the other
signaling pathways responsible for the induction of other
inflammatory mediators and NO generation by nicotine
must be evaluated in further studies.Conflicts of interest
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